The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer.
| Image |  |
|---|---|
| Description | scientific article published in November 2016 |
| Author/s | |
| Publication date | November 1, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |